Rare diseases
Investigational molecules
Locations
101 Rue De Tolbiac, 75013 Paris, France
Research activity includes Alzheimer's disease, Lewy body dementia, Parkinson's disease, prodromal Parkinson's disease, semantic variant primary progressive aphasia, organic amnesia syndrome, and memory disorders across different clinical presentations. The funded studies use PET imaging, MRI, and functional neuroimaging to examine tau pathology, serotonergic dysfunction, microglial activation, and memory network integrity.
Additional work spans comatose traumatic brain injury and dopaminergic pathway abnormalities linked to recovery assessment.
Inserm runs clinical trials in conditions such as HIV infection, Dementia Alzheimer's type, COVID-19, Schizophrenia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
